FDA Adverse Event Malfunction Summary report: N

TELIGEN

MDR report key: 1871879 · Received October 16, 2010

Report

Report Number
2124215-2010-17595
Event Type
Malfunction
Date Received
October 16, 2010
Date of Event
August 27, 2010
Report Date
September 3, 2010
Manufacturer
GUIDANT CRM CLONMEL IRELAND
Product Code
LWS
Product Problem
Yes
Report Source
Manufacturer report
Reporter Occupation
MEDICAL EQUIPMENT COMPANY TECHNICIAN/REPRESENTATIVE

Narratives

Additional Manufacturer Narrative · 1

ADDITIONAL INFORMATION WAS RECEIVED FROM THE FIELD INDICATING THE PATIENT WILL CONTINUE TO BE MONITORED AT THIS TIME. SHOULD ADDITIONAL INFORMATION BECOME AVAILABLE THIS EVENT WILL BE UPDATED.

Additional Manufacturer Narrative · 1

THE AVAILABLE INFORMATION SUGGESTS THIS DEVICE REMAINS IN SERVICE. SHOULD ADDITIONAL INFORMATION BECOME AVAILABLE THIS EVENT WILL BE UPDATED.

Description of Event or Problem · 1

BOSTON SCIENTIFIC CRM RECEIVED INFORMATION THAT THIS IMPLANTABLE CARDIOVERTER DEFIBRILLATOR (ICD) EXHIBITED ATRIAL PACING IMPEDANCE MEASUREMENTS GREATER THAN 2000 OHMS. THERE WAS NO EVIDENCE OF NOISE. TECHNICAL SERVICES DISCUSSED THE OPTIONS OF CONTINUED MONITORING, DEVICE REPROGRAMMING TO VVI, OR REPLACING THE LEAD. NO ADVERSE PATIENT EFFECTS WERE REPORTED.

Description of Event or Problem · 1

--

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 TELIGEN IMPLANTABLE CARDIOVERTER DEFIBRILLATOR LWS GUIDANT CRM CLONMEL IRELAND E110

Patients

Seq Age Sex Outcome Treatment
1 87 YR (B)(4)| A155| 0158| E110